Agent for treating thrombosis and phosphodiesterase inhibitor
AssigneeOtsuka Pharmaceutical Co., Ltd.
InventorsTakafumi Fujioka, Shuji Teramoto, Michiaki Tominaga, Yoichi Yabuuchi
Life of this patent
Estimating the term…
Loading patent…
AssigneeOtsuka Pharmaceutical Co., Ltd.
InventorsTakafumi Fujioka, Shuji Teramoto, Michiaki Tominaga, Yoichi Yabuuchi
Estimating the term…
A pharmaceutical preparation comprising at least one compound selected from the group consisting of carbostyril derivatives having the general formula: ##STR1## wherein R.sup.1 is hydrogen or a lower alkyl group optionally having hydroxy group as a substituent; R.sup.2 is a phenyl(lower alkyl) group optionally having 1 to 3 substituents selected from the group consisting of a lower alkoxy group and a halogen atom on the phenyl ring, pyridyl(lower alkyl) group, or a group of the formula --A--NR.sup.3 R.sup.4 (wherein A is a lower alkylene group, R.sup.3 and R.sup.4 are the same or different and represent a lower alkyl group or phenyl group), and a salt thereof, which is useful as an agent for treating thrombosis, more particularly, as an agent for inhibiting platelet aggregation and as an agent for platelet aggregate dissociation.
A method for treating thrombosis comprising administering to a subject an anti-thrombotic effective amount of a carbostyril derivative of the formula:
A method for dissociating platelet aggregation comprising administering to subject a platelet aggregation dissociation effective amount of a .carbostyril derivative of the formula:
Dependencies are inferred from the claim text.